Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

China Pioneer Pharma Holdings Ltd

1345
Current price
2.35 HKD +0.1 HKD (+4.44%)
Last closed 2.35 HKD
ISIN KYG2162L1068
Sector Healthcare
Industry Pharmaceutical Retailers
Exchange Hong Kong Stock Exchange
Capitalization 2 743 656 130 HKD
Yield for 12 month +28.42 %
1Y
3Y
5Y
10Y
15Y
1345
21.11.2021 - 28.11.2021

Shanghai Pioneer Holding Ltd, an investment holding company, markets, promotes, and sells pharmaceutical products and medical devices primarily in the People's Republic of China. The company offers pharmaceutical products for ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas. It also sells medical devices, including ophthalmology, orthopedics, odontology, and wound care products. In addition, the company engages in sale of ancillary tools, dental devices, and imported in-licensed prescription products, as well as accessories leasing; research and development of denture and implants dentistry; Medical research and experimental development; and provision of metal finishing services. It sells its products to hospitals and medical institutions, and pharmacies. The company was formerly known as China Pioneer Pharma Holdings Limited. Shanghai Pioneer Holding Ltd was founded in 1996 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pioneer Holding Ltd is a subsidiary of Pioneer Pharma (BVI) Co., Ltd. Address: No.15, Lane 88 Wuwei Road, Shanghai, China, 200331

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

26.40 HKD

P/E ratio

16.79

Dividend Yield

3.07 %

Current Year

+1 567 227 766 HKD

Last Year

+1 556 591 001 HKD

Current Quarter

+737 171 948 HKD

Last Quarter

Current Year

+668 475 629 HKD

Last Year

+780 742 368 HKD

Current Quarter

+316 539 050 HKD

Last Quarter

Key Figures 1345

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 202 001 507 HKD
Operating Margin TTM 10.99 %
PE Ratio 16.79
Return On Assets TTM 7.59 %
PEG Ratio
Return On Equity TTM 13.66 %
Wall Street Target Price 26.40 HKD
Revenue TTM 1 648 318 514 HKD
Book Value 0.96 HKD
Revenue Per Share TTM
Dividend Share 0.066 HKD
Quarterly Revenue Growth YOY 11.00 %
Dividend Yield 3.07 %
Gross Profit TTM 702 553 715 HKD
Earnings per share
Diluted Eps TTM
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY 22.70 %
Profit Margin 9.93 %

Dividend Analytics 1345

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

153.00 %

Dividend History 1345

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.070
Ex Dividend Date 30.10.2024
Forward Annual Dividend Yield 3.06 %
Last Split Factor
Payout Ratio 33.98 %
Last Split Date
Dividend Date

Stock Valuation 1345

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 16.79
Forward PE
Enterprise Value Revenue 1.53
Price Sales TTM 1.66
Enterprise Value EBITDA 11.83
Price Book MRQ 2.31

Financials 1345

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 1345

For 52 weeks

1.27 HKD 2.45 HKD
50 Day MA 2.21 HKD
Shares Short Prior Month
200 Day MA 2.05 HKD
Short Ratio
Shares Short
Short Percent